ArticleArtificial organs2025
New Findings on Pulsatile ECMO: Verification of the Potential to Improve Antithrombogenicity of a Membrane Oxygenator Using Pump-Generated Pulsatile Flow in an Innovative Animal Model.
Article in Artificial organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundExtracorporeal membrane oxygenation (ECMO) provides mechanical circulatory and respiratory support. However, thrombus formation in the circuit can lead to hemorrhagic complications, requiring improvements in ECMO anti-thrombogenicity. Few studies have reported the effect of pulsatile flow on thrombus formation in ECMO circuits. This study evaluated how pulsatile flow affects thrombus formation inside the membrane oxygenator.
methodsThis study was conducted in pigs (n = 5) using an experimental model in which each pig was connected to two different ECMO circuits: one with steady flow (via the jugular vein and carotid artery) and the other with pulsatile flow (via the femoral vein and artery). The pulsatile waveform was generated as an upward sinusoidal waveform added to the baseline frequency. Both circuits were set to a mean flow rate of 2 L/min and operated for 4 h without anticoagulation. Thrombus formation in the membrane oxygenators was observed during and after circulation. The thrombus area was quantified using image analysis.
resultsAll experiments were completed with stable hemodynamics. The pressure in the pulsatile circuit was confirmed to be a pulsatile waveform. The thrombus area in the steady flow circuits was 81.5%, 10.6%, 42.1%, 60.2%, and 96.7%, while those in the pulsatile flow circuits were 6.2%, 5.2%, 8.4%, 9.9%, and 65.8%, respectively. The thrombus area in the pulsatile flow circuit tended to be smaller than that in the steady flow circuit.
conclusionsPulsatile flow with a specific waveform may reduce thrombus formation in membrane oxygenators, potentially enhancing the anti-thrombogenicity of ECMO circuits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.